← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors.

Aslamuzzaman Kazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

50 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31227505